Page last updated: 2024-10-24

carbazilquinone and Spinal Cord Neoplasms

carbazilquinone has been researched along with Spinal Cord Neoplasms in 1 studies

Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.

Spinal Cord Neoplasms: Benign and malignant neoplasms which occur within the substance of the spinal cord (intramedullary neoplasms) or in the space between the dura and spinal cord (intradural extramedullary neoplasms). The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mori, T1
Kayama, T1
Katakura, R1

Other Studies

1 other study available for carbazilquinone and Spinal Cord Neoplasms

ArticleYear
[Medulloblastoma with intractable ascites treated by carboquone--a complication of a ventriculoperitoneal shunt (author's transl)].
    No shinkei geka. Neurological surgery, 1977, Volume: 5, Issue:12

    Topics: Ascites; Azirines; Brain Neoplasms; Carbazilquinone; Cerebrospinal Fluid Shunts; Child, Preschool; F

1977